Trial NCT04834349

View at ClinicalTrials.gov 
Org. Study IDs: 2020-0354
Secondary IDs: 2020-0354 NCI-2021-00123

Last trial update was posted on 2023-09-13

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma Carcinoma, Squamous Cell Recurrence Squamous Cell Carcinoma of Head and Neck

Other Conditions

Recurrent Head and Neck Squamous Cell Carcinoma Unresectable Head and Neck Squamous Cell Carcinoma

Stopping Reasons

No participants were enrolled

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID